Neuro part 2 classes Flashcards
Alpha & Beta adrenergic agonists MEDS and prototype
- Epinephrine (adrenalin): shock, glaucoma, prolongs effects of regional anesthetic
- Norepinephrine (Levophed) : tx shock or during cardiac arrest to get sympathetic activity
- Dopamine: shock
- Dobutamine: congestive heart failure
- Ephedrine: seasonal rhinitis, hypotensive episodes
PROTOTYPE: DOPAMINE
Ectopic beats
MOA of Alpha & Beta adrenergic agonists
Effects mediated by receptors in target organs
HR increases
Bronchi dilate, RR increases
Blood vessels constrict, BP increases
IOP decreases, pupils dilate
Glycogenolysis occurs
Sweating occurs
Indications and CI of alpha and beta agonists
Indications:
Hypotension, hypotensive shock
Bronchospasm, asthma
Ci:
Pheochromocytoma
Tachyarrhythmia, v fib
Hypovolemia
Peripheral vascular disease
AE and DDI alpha and beta agonists
AE:
Cardiac – htn arrhythmia, palpitation, angina
Resp – dyspnea
GI – n/v/c
CNS – h/a, sweating, tension, piloerection
Labs - hypokalemia
DDI:
TCAs, MAOIs
HTN causing meds, OTCs, herbals
Alpha selective adrenergic agonists MEDS and prototype
- Clonidine (catapres): essential htsn, chronic pain, opiate w/d
- Dexmedetomidine (precedex): sedation of intubated/ ventilated clients
- Guanfacine (intuniv): ADHD
- Midodrine (orvaten): otho hypotension
- Phenylephrine: cold/allx, preoperative, hypotsn, CVT, glaucoma, OM, vasodilatory shock
PROTOTYPE: Phenylephrine
MOA and CI to Alpha selective adrenergic agonists
MOA:
Stimulate alpha receptors
CI:
Severe HTN
Narrow angle glaucoma
Hypotension, bradycardia
CV disease, vasomotor spasm
Thyrotoxicosis, DM
Renal / Hepatic impairment
AE and DDI to alpha selective agonists
AE:
Cardiac – arrhythmia, BP changes, PV problems
GI – n/v, anorexia
GU – decreased UOP, sexual dysfunction
CNS – anxiety, restlessness, fatigue, depression, blurred vision, sensitivity to light
DDI:
TCAs, MAOIs
CNS depressants
Antihypertensives
Digoxin
Nursing implications to alpha selective agonists
taper for d/c (2-4 days), monitor GI, UOP
Beta selective adrenergic agonists
MEDS and prototype
Albuterol: bronchospasm
Levalbuterol (Xopenex): asthma, bronchospasm
Isoproterenol: Treatment of shock, cardiac standstill, prevention of bronchospasm during anesthesia. Reserved for emergencies due to adverse effects. Short duration = not generally used for tx. Of asthma
Metaproterenol: asthma, bronchospasm
Salmeterol (serevent diskus): asthma, bronchospasm, COPD
Terbutaline: asthma, bronchospasm
PROTOTYPE: Isoproterenol
Monitor pulmonary, thyroid, cv, cns
MOA and indications of beta selective agonists
MOA:
Stimulate beta receptors
Increase heart rate, conductivity, and contractility, bronchodilation, blood flow to skeletal muscles, and relaxation of uterus
Indications:
Bronchospasm
CI to beta selective agonists
- Pulm HTN, tachyarrhythmia, angina, DM, thyroid dz, vasomotor dz, CVA
- Eclampsia/uterine hemorrhage/IU death
- Pregnancy
- Renal / Hepatic impairment
AE to beta selective agonists
Cardiac – tachycardia, angina, MI, palpitations
Resp – SOB, cough, bronchospasm, pulm edema
GI – n/v, anorexia
Labs - hypokalemia
CNS – anxiety, restlessness, fatigue, fear, tremor, h/a, sweating, pupil dilation
DDI to beta selective agonists
Sympathomimetics
Beta-adrenergic blockers
Nonselective adrenergic blockers
MEDS and prototype
- Amiodarone (cordarone): ventricular arrhythmia, afib
- Carvedilol (coreg): Hypertension, congestive heart failure (adult), Left ventricular dysfunction after MI
- Labetalol (normodyne, trandate): Hypertension, HTN assoc. with pheochromocytoma, clonidine withdrawal
PROTOTYPE: Labetalol
Gastric pain
MOA and indications of Nonselective adrenergic blockers
MOA:
- Competitively block the effects of norepinephrine at the alpha and beta receptors throughout the SNS
- Prevents norepinephrine from activating the receptor lower blood pressure, slower pulse, and increased renal perfusion
Indications:
Htsn, arrhythmia
CI to Nonselective adrenergic blockers
Bradycardia/heart block/HF
DM
Bronchospasm/asthma
Pregnancy / Lactation
AE to Nonselective blockers
CNS – dizziness, paresthesia, insomnia, depression, fatigue, vertigo
GI – n/v/d, anorexia
Card – arrhythmia, hypotension, HF, pulmonary edema, CVA
Resp – bronchospasm, cough, rhinitis
Lab – hypoglycemia, hepatic injury
DDI to nonselective blockers
Antidiabetic agents
CCBs
QT prolonging antiarrhythmics
Nonselective alpha adrenergic blocker
MED
Phentolamine (Reitine, Oraverse) :
- Prevention of cell death/tissue sloughing after extravasation of NE, dopamine
- Prevention of severe HTN during pheochromocytoma surgery
- Reversal of anesthesia
MOA of Phentolamine
- Blocks postsynaptic alpha1 adrenergic receptors (Decreased sympathetic tone in vasculature :Vasodilation)
- Blocks presynaptic alpha2 receptors (Prevents feedback NE release : Increase in reflex tachy d/t hypotension_
- Local vasodilation and return of blood to site of injection
Indications, CI, AE of Phentolamine
Indications:
Htsn, prevention of cell death
CI:
CAD/MI
Preg/lact
AE:
Extension of therapeutic effects
CV – hypotension, angina, MI, flushing, tachycardia, arrhythmia, CVA
CNS – h/a, weakness, dizziness
GI - n/v/d
DDI to nonselective alpha blockers
Ephedrine/epinephrine
EtOH
Alpha 1- selective antagonists
Doxazosin: BPH, htsn
Prazosin : htsn
Terazosin: BPH, htsn
Tamsulosin/Alfuzosin: BPH
Silodosin: BPH
PROTOTYPE: Doxazosin
Sexual dysfunction
MOA alpha 1 antagonists
Block the postsynaptic alpha 1- receptor sites
decrease in vascular tone and vasodilation = decrease BP
Block the smooth muscle receptors in the prostate and urinary bladder
relaxation of bladder and prostate, improved flow of urine